What is hypophosphatasia (low ALP)?

Hypophosphatasia is a rare genetic disorder causing low alkaline phosphatase (ALP) levels, leading to defective bone and tooth mineralization. Symptoms range from mild dental issues to severe skeletal problems, with treatment focusing on enzyme replacement therapy and supportive care.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Hypophosphatasia and Low ALP

Hypophosphatasia (HPP) is a rare inherited metabolic disorder characterized by abnormally low levels of alkaline phosphatase (ALP), an enzyme crucial for bone and tooth mineralization. This genetic condition affects approximately 1 in 100,000 to 1 in 300,000 live births, though milder forms may be more common and often go undiagnosed.

The disorder results from mutations in the ALPL gene, which provides instructions for making tissue-nonspecific alkaline phosphatase (TNSALP). When this enzyme doesn't function properly, it leads to the accumulation of substances that should be broken down, particularly inorganic pyrophosphate, which inhibits proper bone mineralization.

The Role of Alkaline Phosphatase in Your Body

Alkaline phosphatase is an enzyme found throughout your body, with particularly high concentrations in the liver, bones, kidneys, and digestive system. Its primary function involves removing phosphate groups from various molecules, a process essential for numerous biological functions.

Types of Hypophosphatasia by Age of Onset

Disease severity generally correlates with age of onset, with earlier presentation indicating more severe forms.
TypeAge of OnsetSeverityKey Features
PerinatalPerinatalBefore/at birthMost severeSkeletal deformities, respiratory failure, high mortality
InfantileInfantile< 6 monthsSevereFailure to thrive, seizures, craniosynostosis
ChildhoodChildhood6 months - 18 yearsModeratePremature tooth loss, short stature, bone pain
AdultAdult> 18 yearsMild to moderateStress fractures, dental problems, osteomalacia
OdontohypophosphatasiaOdontohypophosphatasiaAny ageMildOnly dental manifestations, no skeletal symptoms

Disease severity generally correlates with age of onset, with earlier presentation indicating more severe forms.

In bone metabolism, ALP plays a critical role by breaking down pyrophosphate, a natural inhibitor of mineralization. This breakdown allows calcium and phosphate to properly deposit in bones and teeth, creating strong, healthy skeletal structures. When ALP levels are too low, this process is disrupted, leading to the characteristic features of hypophosphatasia.

Understanding your ALP levels through regular biomarker testing can help identify potential issues early. If you're concerned about your bone health or have unexplained symptoms, comprehensive testing can provide valuable insights into your metabolic health.

Types and Severity of Hypophosphatasia

Hypophosphatasia presents in several forms, classified primarily by age of onset and severity. Understanding these different types is crucial for proper diagnosis and treatment planning.

Perinatal Hypophosphatasia

The most severe form appears before birth or shortly after. Affected infants may have profound skeletal abnormalities visible on prenatal ultrasounds, including shortened limbs, soft skull bones, and chest deformities. This form often leads to respiratory failure due to underdeveloped lungs and chest wall abnormalities.

Infantile Hypophosphatasia

Symptoms appear within the first six months of life and include poor feeding, failure to thrive, delayed motor milestones, and increased calcium levels in blood and urine. Infants may develop craniosynostosis (premature fusion of skull bones) and experience seizures due to vitamin B6 deficiency.

Childhood and Adult Forms

Milder forms manifest later in life with symptoms like premature tooth loss, frequent fractures, muscle weakness, and joint pain. Adults may experience stress fractures, particularly in the feet, and develop calcium deposits in kidneys or joints. Many adults with mild hypophosphatasia remain undiagnosed for years.

Recognizing Symptoms of Low ALP

The symptoms of hypophosphatasia vary widely depending on the severity and age of onset. Early recognition of these symptoms can lead to timely diagnosis and appropriate management.

Skeletal and Dental Manifestations

  • Premature loss of baby teeth (before age 5) with intact roots
  • Adult tooth loss or severe dental problems
  • Delayed walking or motor milestones in children
  • Bowed legs or knock knees
  • Short stature
  • Frequent fractures or stress fractures
  • Bone pain and joint problems
  • Osteomalacia (soft bones) in adults

Systemic Symptoms

  • Muscle weakness and pain
  • Fatigue and reduced exercise tolerance
  • Breathing difficulties (in severe cases)
  • Seizures (due to vitamin B6 deficiency)
  • Kidney problems from calcium accumulation
  • Headaches and increased intracranial pressure
  • Failure to thrive in infants
  • Delayed growth and development

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnosis and Testing for Hypophosphatasia

Diagnosing hypophosphatasia requires a combination of clinical evaluation, laboratory testing, and sometimes genetic analysis. The cornerstone of diagnosis is finding persistently low ALP levels in the context of compatible symptoms.

Laboratory Testing

The primary diagnostic test measures serum alkaline phosphatase levels. In hypophosphatasia, ALP levels are consistently below the age-adjusted reference range. However, it's important to note that ALP levels naturally vary with age, being highest during periods of rapid growth.

Additional laboratory tests may include:

  • Vitamin B6 levels (often elevated)
  • Phosphoethanolamine in urine (typically increased)
  • Inorganic pyrophosphate levels
  • Calcium and phosphate levels
  • Parathyroid hormone (PTH) to rule out other conditions

Regular monitoring of these biomarkers is essential for managing hypophosphatasia and adjusting treatment plans. Comprehensive metabolic testing can help track your bone health markers and overall metabolic status over time.

Genetic Testing

Genetic testing for ALPL gene mutations can confirm the diagnosis and help with family planning. Over 400 different mutations have been identified, and the specific mutation can sometimes predict disease severity. Genetic counseling is recommended for affected individuals and their families.

Treatment Options and Management Strategies

Treatment for hypophosphatasia has evolved significantly with the introduction of enzyme replacement therapy. Management strategies vary based on disease severity and specific symptoms.

Enzyme Replacement Therapy

Asfotase alfa (Strensiq) is an FDA-approved enzyme replacement therapy that provides a modified version of the missing ALP enzyme. Administered as subcutaneous injections, this treatment has shown significant improvements in bone mineralization, growth, and respiratory function in severe forms of hypophosphatasia.

Supportive Care

Comprehensive supportive care includes:

  • Pain management with appropriate medications
  • Physical therapy to maintain mobility and strength
  • Occupational therapy for daily living activities
  • Dental care with specialized monitoring
  • Nutritional support and dietary counseling
  • Orthopedic interventions for fractures or deformities
  • Respiratory support when needed

Monitoring and Follow-up

Regular monitoring is crucial for managing hypophosphatasia effectively. This includes periodic assessment of ALP levels, bone density scans, dental examinations, and evaluation of growth and development in children. Adults require ongoing monitoring for complications like stress fractures and kidney stones.

Living with Hypophosphatasia

Managing hypophosphatasia requires a multidisciplinary approach and lifestyle adaptations. Understanding how to optimize your health while living with this condition can significantly improve quality of life.

Exercise and Physical Activity

While high-impact activities may need to be avoided, appropriate exercise is beneficial for maintaining muscle strength and bone health. Low-impact activities like swimming, cycling, and yoga can help maintain fitness without excessive stress on bones. Working with a physical therapist familiar with hypophosphatasia can help develop a safe exercise program.

Nutrition Considerations

Proper nutrition supports overall health and bone metabolism. Key considerations include:

  • Adequate protein intake for muscle maintenance
  • Balanced calcium intake (avoiding excess)
  • Vitamin D optimization through testing and supplementation
  • Anti-inflammatory foods to reduce pain and inflammation
  • Avoiding excessive phosphate intake
  • Maintaining healthy body weight to reduce skeletal stress

If you're looking to better understand your nutritional status and how it relates to your bone health, consider uploading your existing blood test results to SiPhox Health's free analysis service. This comprehensive analysis can help identify nutritional deficiencies and provide personalized recommendations for optimizing your health.

The Importance of Early Detection and Ongoing Monitoring

Early detection of hypophosphatasia can significantly impact treatment outcomes and quality of life. This is particularly important for milder forms that may go undiagnosed for years. Regular screening of ALP levels during routine blood work can help identify potential cases.

For individuals with a family history of hypophosphatasia or unexplained dental or bone problems, proactive testing is especially important. Genetic counseling can help families understand inheritance patterns and make informed decisions about family planning.

Ongoing monitoring allows for timely adjustments to treatment plans and early intervention for complications. This includes regular assessment of bone density, dental health, kidney function, and overall metabolic status. Tracking these markers over time provides valuable insights into disease progression and treatment effectiveness.

Future Directions and Research

Research into hypophosphatasia continues to advance our understanding of this complex disorder. Current areas of investigation include developing new therapeutic approaches, understanding the full spectrum of ALPL mutations, and improving diagnostic methods for mild cases.

Gene therapy represents a promising future direction, potentially offering a one-time treatment that could restore normal ALP production. Clinical trials are also exploring new medications to address specific symptoms and complications of hypophosphatasia.

As our understanding of this condition grows, the importance of comprehensive health monitoring becomes increasingly clear. Regular biomarker testing can help track not just ALP levels but also related metabolic markers that impact bone health and overall wellbeing.

References

  1. Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233-246.[PubMed][DOI]
  2. Mornet E. Hypophosphatasia. Metabolism. 2018;82:142-155.[PubMed][DOI]
  3. Shapiro JR, Lewiecki EM. Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations. J Bone Miner Res. 2017;32(10):1977-1980.[PubMed][DOI]
  4. Kishnani PS, et al. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017;122(1-2):4-17.[PubMed][DOI]
  5. Hofmann C, et al. Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study. J Clin Endocrinol Metab. 2019;104(7):2735-2747.[PubMed][DOI]
  6. Berkseth KE, et al. Clinical spectrum of hypophosphatasia diagnosed in adults. Bone. 2013;54(1):21-27.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ALP at home?

You can test your ALP at home with SiPhox Health's Heart & Metabolic Program, which includes ALP testing along with other important liver and metabolic markers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is the normal range for alkaline phosphatase?

Normal ALP ranges vary by age and sex. For adults, typical ranges are 44-147 IU/L, but children and adolescents have higher normal ranges due to bone growth. In hypophosphatasia, ALP levels are persistently below the age-appropriate reference range.

Can hypophosphatasia be cured?

While there's no cure for hypophosphatasia, enzyme replacement therapy with asfotase alfa can significantly improve symptoms and quality of life, especially in severe forms. Supportive care and symptom management help many people live full, active lives.

Is hypophosphatasia hereditary?

Yes, hypophosphatasia is an inherited genetic disorder caused by mutations in the ALPL gene. It can be inherited in an autosomal recessive pattern (most common) or autosomal dominant pattern, depending on the specific mutation.

What are the first signs of hypophosphatasia in adults?

Common early signs in adults include premature tooth loss, stress fractures (especially in feet), chronic bone or muscle pain, and fatigue. Many adults are diagnosed after experiencing recurrent fractures or dental problems that prompt further investigation.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details